| 31/05/24 | 15:56:45 | 31 May 2024 | | Block listing returns |
| 31/05/24 | 11:24:47 | 31 May 2024 | | Result of General Meeting |
| 30/05/24 | 07:00:11 | 30 May 2024 | | Result of Open Offer and REX Offer |
| 24/05/24 | 07:00:04 | 24 May 2024 | | Initial orders of the Genedrive MT-RNR1 Products |
| 21/05/24 | 11:00:01 | 21 May 2024 | | Key CYP2C19-ID test performance milestone achieved |
| 15/05/24 | 07:00:05 | 15 May 2024 | | Amendment to Open Offer timetable |
| 14/05/24 | 07:00:14 | 14 May 2024 | | Publication of Circular and Notice of GM |
| 10/05/24 | 07:00:08 | 10 May 2024 | | Completion of placing |
| 09/05/24 | 16:49:00 | 9 May 2024 | | Proposed REX Retail Offer |
| 09/05/24 | 16:48:00 | 9 May 2024 | | Proposed Fundraise for a minimum of £6.0 million |
| 24/04/24 | 15:36:57 | 24 Apr 2024 | | Clinical Trial Agreement |
| 03/04/24 | 17:00:00 | 3 Apr 2024 | | Application for Listing & Total Voting Rights |
| 03/04/24 | 07:00:05 | 3 Apr 2024 | | NICE recommends the Genedrive CYP2C19-ID Kit |
| 28/03/24 | 07:00:09 | 28 Mar 2024 | | Half-year Report |
| 26/03/24 | 07:00:17 | 26 Mar 2024 | | Investor presentation |
| 19/03/24 | 15:53:17 | 19 Mar 2024 | | Application for Listing & Total Voting Rights |
| 15/03/24 | 12:30:35 | 15 Mar 2024 | | Receipt of R&D tax credit |
| 19/02/24 | 07:00:03 | 19 Feb 2024 | | NICE Early Value Assessment update |
| 06/02/24 | 14:03:30 | 6 Feb 2024 | | Director/PDMR Shareholding |
| 02/02/24 | 15:35:55 | 2 Feb 2024 | | Total Voting Rights |
| 19/01/24 | 16:14:03 | 19 Jan 2024 | | Total Voting Rights |
| 15/01/24 | 15:21:53 | 15 Jan 2024 | | Total Voting Rights |
| 10/01/24 | 07:00:03 | 10 Jan 2024 | | Total Voting Rights |
| 02/01/24 | 07:00:03 | 2 Jan 2024 | | Equity Prepayment Facility drawdown |
| 29/12/23 | 11:44:56 | 29 Dec 2023 | | Result of AGM |
| 20/12/23 | 16:57:36 | 20 Dec 2023 | | Total Voting Rights |
| 20/12/23 | 07:00:13 | 20 Dec 2023 | | Initial overseas orders of MT-RNR1 ID kit |
| 07/12/23 | 07:00:13 | 7 Dec 2023 | | Total Voting Rights |
| 06/12/23 | 07:00:17 | 6 Dec 2023 | | Posting of annual report and notice of AGM |
| 06/12/23 | 07:00:11 | 6 Dec 2023 | | Total Voting Rights |
| 04/12/23 | 13:13:36 | 4 Dec 2023 | | MT-RNR1 ID kit adopted for routine use in Brighton |
| 30/11/23 | 17:29:51 | 30 Nov 2023 | | Block listing Interim Review |
| 30/11/23 | 07:00:14 | 30 Nov 2023 | | Final Results |
| 29/11/23 | 17:25:42 | 29 Nov 2023 | | Equity Prepayment Facility drawdown |
| 16/11/23 | 07:00:15 | 16 Nov 2023 | | Notice of Results |
| 20/10/23 | 10:52:13 | 20 Oct 2023 | | Total Voting Rights |
| 28/09/23 | 12:35:06 | 28 Sept 2023 | | c£1.2m grant awarded |
| 21/09/23 | 14:39:11 | 21 Sept 2023 | | Application for listing & total voting rights |
| 11/09/23 | 14:17:33 | 11 Sept 2023 | | Board changes |
| 06/09/23 | 07:00:03 | 6 Sept 2023 | | UKCA marking achieved for new CYP2C19 test |
| 04/08/23 | 16:00:01 | 4 Aug 2023 | | Total Voting Rights |
| 05/07/23 | 09:11:45 | 5 Jul 2023 | | Equity Prepayment Facility drawdown |
| 16/06/23 | 14:28:31 | 16 Jun 2023 | | Holding(s) in Company |
| 16/06/23 | 07:00:03 | 16 Jun 2023 | | Multi-partner grant awarded |
| 02/06/23 | 12:25:35 | 2 Jun 2023 | | Equity Prepayment Facility drawdown |
| 31/05/23 | 07:00:07 | 31 May 2023 | | Block Listing Returns |
| 19/05/23 | 07:00:02 | 19 May 2023 | | NICE recommends CYP2C19 genotyping |
| 15/05/23 | 17:56:08 | 15 May 2023 | | Block Listing Application to AIM |
| 11/05/23 | 11:58:13 | 11 May 2023 | | Result of General Meeting |
| 24/04/23 | 11:54:39 | 24 Apr 2023 | | Publication of Circular and Notice of GM |
